● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● The group's activity appears highly profitable thanks to its outperforming net margins.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.